Literature DB >> 11430878

FK506 ameliorates the discrimination learning impairment due to preventing the rarefaction of white matter induced by chronic cerebral hypoperfusion in rats.

K Tanaka1, K Hori, N Wada-Tanaka, M Nomura, N Ogawa.   

Abstract

We examined the effects of the immunosuppressant tacrolimus (FK506) on the discrimination learning impairment induced by chronic cerebral hypoperfusion in rats. Chronic cerebral hypoperfusion was prepared by permanent ligation of bilateral common carotid arteries for male Wistar rats aged 9 weeks. FK506 (0.05 mg/kg, s.c.) recovered the learning impairment and also prevented the rarefaction of white matter and striatal neuronal cell damage. Our findings suggest that FK506 ameliorates the learning impairment mainly due to preventing neuropathological alterations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11430878     DOI: 10.1016/s0006-8993(01)02537-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

Review 1.  [Therapeutic hypothermia after cardiac arrest].

Authors:  E Popp; F Sterz; B W Böttiger
Journal:  Anaesthesist       Date:  2005-02       Impact factor: 1.041

2.  AT1 receptor blocker candesartan-induced attenuation of brain injury of rats subjected to chronic cerebral hypoperfusion.

Authors:  Veysel Haktan Ozacmak; Hale Sayan; Alpay Cetin; Aysenur Akyildiz-Igdem
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

3.  Chronic cerebral hypoperfusion induces striatal alterations due to the transient increase of NO production and the depression of glutathione content.

Authors:  Ken-Ichi Tanaka; Naoko Wada-Tanaka; Ikuko Miyazaki; Masahiko Nomura; Norio Ogawa
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

4.  Intra-CA1 administration of FK-506 (tacrolimus) in rat impairs learning and memory in an inhibitory avoidance paradigm.

Authors:  Amirmasoud Hadjiasgary; Hamid Reza Banafshe; Abolfazl Ardjmand
Journal:  Iran J Basic Med Sci       Date:  2015-02       Impact factor: 2.699

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.